Inhibition of α-Glucosidase by Abietane-Type Diterpenoids Isolated from Roots of Salvia miltiorrhiza
	    		
		   		
		   			
		   		
	    	
    	- Author:
	        		
		        		
		        		
			        		Nguyen Viet PHONG
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Le Thi THANH
			        		
			        		;
		        		
		        		
		        		
			        		Mi Jeong KWON
			        		
			        		;
		        		
		        		
		        		
			        		You Mie LEE
			        		
			        		;
		        		
		        		
		        		
			        		Byung Sun MIN
			        		
			        		;
		        		
		        		
		        		
			        		Jeong Ah KIM
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - From:Natural Product Sciences 2023;29(4):349-356
 - CountryRepublic of Korea
 - Language:English
 - Abstract: Salvia miltiorrhiza is a traditional medicinal plant used in Asian medicine for various therapeutic purposes. This plant contains numerous bioactive secondary metabolites, particularly abietane-type diterpenoids. In this study, 16 abietane-type diterpenoids were isolated from S. miltiorrhiza root extracts and structurally identified through advanced spectroscopic techniques. Among them, tanshinone IIA (6) and 15,16-dihydrotanshinone I (11) exhibited potent α-glucosidase inhibition, with IC 50 values of 48.38 ± 0.57 and 48.02 ± 0.47 µM, respectively. Enzyme kinetic studies revealed that these compounds served as non-competitive inhibitors of α-glucosidase. Our findings indicate that natural compounds from S. miltiorrhiza show promise as safe and effective α-glucosidase inhibitors, providing an alternative approach to diabetes treatment. This study contributes to the growing interest in utilizing natural sources for α-glucosidase inhibition and their potential application in healthcare and disease management.
 
            